1. (3) Kim, G.C., Kim, G.J., Park, S.R., Jeon, S.M., Seo, H.J., Iza, F. and Lee, J.K., Air plasma coupled with antibody-conjugated nanoparticles: a new weapon against cancer, Journal of Physics D: Applied Physics, Vol. 42, No. 3 (2009), pp. 032005.
2. (4) Daniels, T.R., Delgado, T., Rodriguez, J.A., Helguera, G. and Penichet, M.L., The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer, Clinical Immunology, Vol. 121, No. 2 (2006), pp. 144-158.
3. (5) Herbst, R.S., Review of epidermal growth factor receptor biology, International Journal of Radiation Oncology · Biology · Physics, Vol. 59, No. 2 (2004), pp.21-26.
4. (6) Rogers, S.J., Harrington, K.J., Rhys-Evans, P., O-Charoenrat, P. and Eccles, S.A., Biological significance of c-erbB family oncogenes in head and neck Cancer, Cancer Metastasis Review, Vol. 24, No. 1 (2005), pp. 47-69.
5. (7) Kalyankrishna, S. and Grandis, J.R., Epidermal growth factor receptor biology in head and neck cancer, Journal of Clinical Oncology, Vol. 24, No.17 (2006), pp. 2666-2672.